The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and patient (pt)-reported outcomes (PROs) in a phase 3, randomized, open-label study evaluating axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in elderly pts with relapsed/refractory (R/R) large B-cell lymphoma (LBCL; ZUMA-7).
 
Jason Westin
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Amgen; AstraZeneca; Bristol-Myers Squibb/Celgene/Juno; Curis; Forty Seven; Genentech/Roche; Iksuda Therapeutics; IMV; Janssen Scientific Affairs; Karyopharm Therapeutics; Kite/Gilead; Merck; Monte Rosa Therapeutics; MorphoSys; Novartis; Umoja Biopharma
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Curis; Forty Seven; Genentech; Janssen; Kite/Gilead; MorphoSys; Novartis
 
Frederick L. Locke
Consulting or Advisory Role - Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Celgene; Cellular Biomedicine Group; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Novartis; Sana Biotechnology; Takeda; Umoja Biopharma
Research Funding - Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Michael Dickinson
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche (I)
Research Funding - Celgene (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche
 
Armin Ghobadi
Honoraria - Kite, a Gilead Company
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Celgene; Kite, a Gilead Company; WUGEN, Inc.
Research Funding - Amgen; Kite, a Gilead Company
 
Mahmoud Elsawy
Honoraria - Bristol-Myers Squibb; Janssen; Kite, a Gilead Company; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Kite, a Gilead Company; Novartis; Pfizer
 
Tom van Meerten
Consulting or Advisory Role - Kite, a Gilead Company
Research Funding - Bristol-Myers Squibb; Kite, a Gilead Company; Merck; Spectrum Pharmaceuticals
 
David Bernard Miklos
Honoraria - fosun Kite Biotechnology; Janssen
Consulting or Advisory Role - Adaptive Biotechnologies; Janssen; Juno/Celgene; Pharmacyclics
Research Funding - Adaptive Biotechnologies; Adicet Bio; Alimera Sciences; Kite, a Gilead company; Novartis; Pharmacyclics; Precision Biosciences; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim)
 
Matthew Ulrickson
Consulting or Advisory Role - Gilead Sciences; Stemline Therapeutics
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune
Honoraria - MorphoSys
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Cidara Therapeutics; Incyte; Kite/Gilead; Medigene; Merck; MolMed; Nektar; NexImmune; Novartis; Omeros; Servier/Pfizer; Vor Biopharma
Research Funding - Incyte (Inst); Kite, a Gilead company (Inst); Miltenyi Biotec (Inst); Nektar (Inst); Novartis (Inst)
 
Umar Farooq
Honoraria - Kite, a Gilead company; Morphosys
Research Funding - Checkmate Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Luciano Wannesson
Consulting or Advisory Role - AstraZeneca Canada; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Roche
Expert Testimony - AstraZeneca; Novartis
 
Lori Ann Leslie
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; BeiGene; Celgene/Bristol-Myers Squibb; Epizyme; Janssen/Pharmacyclics; Kite/Gilead; Merck; Seagen; TG Therapeutics
Speakers' Bureau - AstraZeneca; BeiGene; Celgene; Epizyme; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Seagen; TG Therapeutics
 
Marie José Kersten
Honoraria - Kite, a Gilead company; Novartis; Roche
Consulting or Advisory Role - Kite, a Gilead Company; Miltenyi Biotec (Inst); Novartis; Takeda (Inst)
Research Funding - Kite, a Gilead company (Inst)
Travel, Accommodations, Expenses - Celgene; Kite, a Gilead Company; Novartis; Roche
 
Caron Alyce Jacobson
Honoraria - Abintus Bio; Bluebird Bio; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; Epizyme; ImmPACT-Bio; Instil Bio; Ipsen; Kite/Gilead; Lonza; Novartis
Consulting or Advisory Role - Abintus Bio; Bluebird Bio; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; Epizyme; ImmPACT-Bio; Instil Bio; Ipsen; Kite/Gilead; Lonza; Novartis
Research Funding - Kite, a Gilead company; Pfizer
 
John M. Pagel
Employment - Loxo
Leadership - Loxo
Stock and Other Ownership Interests - Loxo
Consulting or Advisory Role - Actinium Pharmaceuticals; AstraZeneca; BeiGene; Epizyme; Gilead Sciences; Loxo; MEI Pharma; MorphoSys; TG Therapeutics
 
Gerald Wulf
Honoraria - hematology today
Consulting or Advisory Role - Clinigen Group; Gilead Sciences; Novartis; Takeda
Speakers' Bureau - Takeda
 
Linqiu Du
Employment - Kite, a Gilead Company
Consulting or Advisory Role - Agios
 
Julia Snider
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Christina Ann To
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
 
Olalekan O. Oluwole
Consulting or Advisory Role - ADC Therapeutics; Bayer; Curio Science; Kite/Gilead; Legend Biotech; Novartis; Pfizer; Spectrum Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst)